Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma

Oncology
Shingo KanajiMasahide Ikeguchi

Abstract

To assess the prognostic value of polo-like kinase 1 (PLK1), an important regulator of cell cycle progression, in patients with gastric carcinoma. PLK1 expression was determined in 160 gastric carcinoma patients by immunohistochemistry and compared with p53 expression and the proliferating cell nuclear antigen-labeling index (PCNA-LI) to evaluate the effect of PLK1 on tumor progression. Furthermore, PLK mRNA expression was determined in 26 advanced gastric cancer patients by reverse transcription-polymerase chain reaction (RT-PCR). PLK mRNA expression was detected in 25 (96.2%) patients by RT-PCR. Immunohistochemical staining revealed PLK1 expression in 84 (52.5%) patients. There were no significant relationships between PLK1 expression and various clinicopathological factors. PLK1 expression was significantly correlated with the PCNA-LI, but not p53 expression. The prognosis of patients with PLK1-positive tumors was significantly worse than that of patients with PLK1-negative tumors (p < 0.05). Moreover, multivariate analysis revealed that PLK1 expression was an independent prognostic factor. Patients with PLK1-positive and high PCNA-LI tumors showed a significantly poorer prognosis than patients with PLK1-negative and/or low ...Continue Reading

References

Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Z S ZengA M Cohen
May 19, 1997·Biochemical and Biophysical Research Communications·M R SmithD K Ferris
Jun 19, 2001·Cancer Letters·N TakaiI Miyakawa
Nov 15, 2001·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·UNKNOWN Japanese Gastric Cancer Association
Jun 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Xiaoqi Liu, Raymond L Erikson
Dec 19, 2002·Journal of the National Cancer Institute·Birgit Spänkuch-SchmittKlaus Strebhardt
Apr 24, 2003·Cancer Science·Takao TakahashiShigetoyo Saji
Feb 19, 2004·British Journal of Cancer·W WeichertS Hauptmann
Jun 3, 2004·Journal of the National Cancer Institute·Birgit SpänkuchKlaus Strebhardt
Jan 22, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-Shaw, Nihal Ahmad
Mar 24, 2005·Virchows Archiv : an International Journal of Pathology·Wilko WeichertCarsten Denkert
Apr 28, 2005·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Wilko WeichertGlen Kristiansen
Oct 21, 2005·World Journal of Gastroenterology : WJG·Wilko WeichertCarsten Denkert

❮ Previous
Next ❯

Citations

Dec 13, 2006·Molecular Diagnosis & Therapy·Casandra AndersonJoseph Kim
Dec 1, 2011·Surgery Today·Takashi Oshima, Munetaka Masuda
Nov 11, 2011·Journal of Medicinal Chemistry·Matthew O DuffeyNatalie D'Amore
Feb 27, 2009·Nature Reviews. Cancer·Steven Christopher Smith, Dan Theodorescu
Jul 31, 2010·Nature Reviews. Drug Discovery·Klaus Strebhardt
May 19, 2012·TheScientificWorldJournal·Petra Hudler
Feb 27, 2008·Acta Pharmacologica Sinica·Lin LiuPing Zou
Jan 24, 2009·Cell Division·Lin-Yu Lu, Xiaochun Yu
Mar 9, 2010·Cell Division·Richa SinghYogeshwer Shukla
Dec 12, 2012·Experimental Hematology & Oncology·Lily Weiß, Thomas Efferth
Sep 3, 2009·World Journal of Gastroenterology : WJG·Zi-Li HeDe-Wu Zhong
Oct 19, 2007·Leukemia & Lymphoma·Lin LiuPing Zou
Nov 14, 2006·Bioorganic & Medicinal Chemistry·Fatih M UckunKatayoon H Emami
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Yan-Bin FengMing-Rong Wang
Mar 15, 2011·Journal of Surgical Oncology·Yan-Wei YeYing-Qiang Shi
Nov 9, 2011·The International Journal of Biochemistry & Cell Biology·Zhao-Xia WangYong-Mei Yin
Apr 7, 2015·Experimental Cell Research·Haiyong WangRandy J Legerski
Jan 28, 2017·Nature Reviews. Cancer·Tobias Otto, Piotr Sicinski
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David OlmosJohann de Bono
Aug 15, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rongfeng LanHui Zhang
Apr 20, 2016·Molecular and Cellular Biology·Ion CristóbalJesús García-Foncillas
Mar 29, 2014·Expert Review of Gastroenterology & Hepatology·Salah-Eddin Al-Batran, Dominique Werner
Nov 22, 2017·British Journal of Pharmacology·Anna Tankiewicz-KwedloDariusz Pawlak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.